Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: a potentially promising tumor vaccine. (Q53175501)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 April 2012

Language	Label	Description	Also known as
English	Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: a potentially promising tumor vaccine.	scientific article published on 3 April 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: a potentially promising tumor vaccine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

1 reference

based on heuristic

inferred from title

author name string

Bai-lin Niu

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Hui-min Du

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Hua-ping Shen

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Zheng-rong Lian

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Jin-zheng Li

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Xing Lai

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Si-dong Wei

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Li-quan Zou

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Jian-ping Gong

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

language of work or name

0 references

publication date

3 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

30

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

23

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

3395-3404

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Spontaneous regression of metastases from melanoma: review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Immunotherapy with dendritic cells for cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Whole tumor antigen vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

The immunogenicity of the hTERT540-548 peptide in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Telomerase therapeutics for cancer: challenges and new directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Telomerase and cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Cancer immunotherapy by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

A listing of human tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Dendritic cell vaccine design: strategies for eliciting peripheral tolerance as therapy of autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Absolute values of dendritic cell subsets in bone marrow, cord blood, and peripheral blood enumerated by a novel method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Progress in human tumour immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Identification of tumour-associated T-cell epitopes for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Autologous CD4/CD8 co-culture assay: a physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Synthesis and bioactivities of two multiple antigen peptides as potential vaccine against schistosoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Strategies and limitations in dendrimeric immunogen synthesis. The influenza virus M2e epitope as a case study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Culture and comparison of feline myeloid dendritic cells vs macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Maintenance and characterization of lymphocytes in human long term bone marrow cultures to study immunotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Single-pass, closed-system rapid expansion of lymphocyte cultures for adoptive cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Dendritic cells and innate defense against tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.045

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.03.045

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22480929

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53175501&oldid=1790257291"